CDC, FDA, Dr. Rochelle Walensky
CDC panel discusses booster shot. Panel votes on booster shot for eligible population.
Where: United States
On September 22nd, the FDA authorized administering a single booster dose of the Pfizer-BioNTech COVID-19 vaccine, six months after completing the primary vaccination series, for eligible individuals.
As per the FDA, eligible individuals include people aged 65 and above, people aged 18-64 at high risk of severe COVID-19 due to underlying health conditions, and individuals aged 18-64 with frequent exposure to the SARS-CoV-2 virus due to their jobs.
On September 23rd, the CDC Advisory Committee on Immunization Practices (ACIP) voted to recommend a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for people aged 65 and above and for people aged 18-64 with underlying health conditions.
The ACIP voted 9-6 against the recommendation of the single booster dose for people aged 18-64 at high risk of COVID-19 complications due to frequent institutional or occupational exposure to the SARS-CoV-2 virus.
Later, CDC Director Dr. Rochelle Walensky, deviating slightly from the ACIP’s recommendations, endorsed the use of booster shots for individuals aged 18-64 with frequent institutional or occupational exposure to the SARS-CoV-2 virus as well.
Direct, authoritative source material on this story.
Articles Citable has ingested related to this story.
Why did we include this story
Most covered story by the media today
of articles referenced this story
Coverage by Media Outlet
Media outlets covering this story along with their positive or negative sentiment toward this story.